Internal Medicine, Endocrinology, Diabetes, & Metabolism · Baton Rouge, LA
NPI
1750308573
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
7373 Perkins Rd
Baton Rouge, LA, 70808
Phone (225) 769-4044
Groups this clinician bills Medicare through
Medicare paid, 2024
$211K
10,038 services
Medicare patients, 2024
1,051
Average age 74
Drug cost, 2024
$3.7M
16,476 prescriptions
Company payments, 2025
$67.56
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joel D Silverberg was code J0897 (injection, denosumab, 1 mg), 1,440 times for 16 patients. In total Joel D Silverberg billed 10,038 services in 83 codes, and Medicare paid $211K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,440 | 16 | $20.44 | $29K |
| 36415 Venipuncture Blood Collection | Office | 896 | 532 | $8.63 | $7,734 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 836 | 509 | $11.46 | $9,578 |
| 99214 Office E&M - Established | Office | 804 | 469 | $81.17 | $65K |
| 84443 Clinical Chemistry | Office | 577 | 450 | $16.44 | $9,487 |
| 83036 Blood Count | Office | 483 | 301 | $9.47 | $4,576 |
| 77085 Standard X-ray | Office | 433 | 433 | $46.91 | $20K |
| 80053 Clinical Chemistry | Office | 321 | 271 | $10.32 | $3,314 |
| 80061 Clinical Chemistry | Office | 292 | 261 | $13.08 | $3,820 |
| 80048 Clinical Chemistry | Office | 257 | 207 | $8.17 | $2,101 |
| 99213 Office E&M - Established | Office | 255 | 241 | $54.98 | $14K |
| 82570 Clinical Chemistry | Office | 235 | 206 | $5.06 | $1,190 |
| 85025 Blood Count | Office | 224 | 195 | $7.58 | $1,698 |
| 82043 Clinical Chemistry | Office | 215 | 191 | $5.64 | $1,212 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 180 | 36 | $4.35 | $783 |
By year: 2022 $208K for 15,007 services; 2023 $252K for 14,994 services; 2024 $211K for 10,038 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 896 | 532 | $8.63 | $7,734 |
| 84443 Clinical Chemistry | 577 | 450 | $16.44 | $9,487 |
| 83036 Blood Count | 483 | 301 | $9.47 | $4,576 |
| 80053 Clinical Chemistry | 321 | 271 | $10.32 | $3,314 |
| 80061 Clinical Chemistry | 292 | 261 | $13.08 | $3,820 |
| 80048 Clinical Chemistry | 257 | 207 | $8.17 | $2,101 |
| 82570 Clinical Chemistry | 235 | 206 | $5.06 | $1,190 |
| 85025 Blood Count | 224 | 195 | $7.58 | $1,698 |
| 82043 Clinical Chemistry | 215 | 191 | $5.64 | $1,212 |
| 81001 Clinical Chemistry | 100 | 82 | $3.09 | $309 |
Medicare prescription drug claims, 2024
In 2024, the drug Joel D Silverberg prescribed most often to Medicare patients was Levothyroxine Sodium, with 2,494 prescriptions and refills. In total Joel D Silverberg wrote 16,476 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 2,494 | 6,722 | 611 | $26K |
| Ozempic Semaglutide | 1,069 | 1,445 | 183 | $1.3M |
| Atorvastatin Calcium Generic | 859 | 2,467 | 248 | $9,962 |
| Metformin Hcl Er Metformin Hcl | 719 | 1,890 | 205 | $10K |
| Jardiance Empagliflozin | 580 | 1,182 | 160 | $662K |
| Synthroid Levothyroxine Sodium | 536 | 1,266 | 130 | $38K |
| Hydrochlorothiazide Generic | 422 | 1,178 | 124 | $2,329 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 420 | 1,057 | 123 | $56K |
| Losartan Potassium Generic | 390 | 1,030 | 108 | $4,189 |
| Amlodipine Besylate Generic | 371 | 1,043 | 98 | $2,005 |
| Alendronate Sodium Generic | 331 | 824 | 103 | $3,369 |
| Metformin Hcl Generic | 313 | 851 | 91 | $2,336 |
| Pravastatin Sodium Generic | 278 | 790 | 84 | $5,837 |
| Gabapentin Generic | 238 | 577 | 62 | $4,347 |
| Novolog Flexpen Insulin Aspart | 226 | 423 | 73 | $58K |
Brand drugs: 5,841 claims; generic drugs: 9,776 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joel D Silverberg $67.56 ($67.56 in general payments such as food, travel and fees) from 2 companies. The largest payer was Ascensia Diabetes Care Us Inc. with $43.52.
| Company | Payments | Amount |
|---|---|---|
| Ascensia Diabetes Care Us Inc. | 1 | $43.52 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $24.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.